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Tobacco smoking is a well-known risk factor for sub-
sequent alcohol abuse, but the neural events under-
lying this risk remain largely unknown. Alcohol and
nicotine reinforcement involve common neural cir-
cuitry, including the mesolimbic dopamine system.
We demonstrate in rodents that pre-exposure to
nicotine increases alcohol self-administration and
decreases alcohol-induced dopamine responses.
The blunted dopamine response was due to
increased inhibitory synaptic transmission onto
dopamine neurons. Blocking stress hormone recep-
tors prior to nicotine exposure prevented all interac-
tions with alcohol that we measured, including the
increased inhibition onto dopamine neurons, the
decreased dopamine responses, and the increased
alcohol self-administration. These results indicate
that nicotine recruits neuroendocrine systems to in-
fluence neurotransmission and behavior associated
with alcohol reinforcement.
INTRODUCTION
Tobacco (nicotine) and alcohol are the two most abused and
costly drugs to society. Epidemiological studies consistently
find a positive correlation between nicotine and alcohol use,
with alcoholism approximately ten times more prevalent in
smokers than in nonsmokers (DiFranza andGuerrera, 1990; Har-
rison et al., 2008; McKee et al., 2007; Schorling et al., 1994;
Weitzman and Chen, 2005). Several studies also show that nico-
tine exposure increases alcohol self-administration (Barrett
et al., 2006; Leˆ et al., 2003; Smith et al., 1999), and smoking,
particularly at an early age, is a significant risk factor for subse-
quent alcohol abuse (Chen et al., 2002; Grant, 1998; Morgen
et al., 2008; Sher et al., 1996; Torabi et al., 1993).
In addition to psychosocial and genetic factors (Bobo and
Husten, 2000; Schlaepfer et al., 2008), evidence suggests that
the interactions between nicotine and alcohol arise from shared
pharmacological actions (Funk et al., 2006; Hurley et al., 2012;
Larsson and Engel, 2004). These drugs activate common neural
substrates, including the mesolimbic dopamine (DA) system (De
Biasi and Dani, 2011; Di Chiara, 2000; Gonzales et al., 2004) and530 Neuron 79, 530–540, August 7, 2013 ª2013 Elsevier Inc.the hypothalamic-pituitary-adrenal (HPA) axis associated with
stress hormone signaling (Armario, 2010; Lutfy et al., 2012; Ri-
chardson et al., 2008). Both the DA and HPA systems are cen-
trally linked to drug use and addiction (Koob and Kreek, 2007;
Ungless et al., 2010).
Alcohol use disorders involve long-term alterations in the
stress hormone systems (Sinha et al., 2011; Vendruscolo et al.,
2012). Stress hormones, such as the glucocorticoids, have a
profound influence on neural function (Joe¨ls and Baram, 2009)
and modulate DA transmission (Barrot et al., 2000; Butts et al.,
2011). Other stress-related neuroactive hormones also modify
GABA transmission (Di et al., 2009; Stell et al., 2003; Wirth,
2011), which may contribute to the pharmacological action of
alcohol (Biggio et al., 2007; Helms et al., 2012; Morrow et al.,
2009).
To simplify this complex and multifaceted interaction between
nicotine and alcohol, we studied how acute nicotine exposure in
naive animals alters subsequent responses to alcohol, including
alcohol-induced DA signals and alcohol self-administration. We
found that pretreatment with nicotine increased subsequent
alcohol self-administration and decreased alcohol-induced
dopamine signals in the ventral tegmental area (VTA) and the nu-
cleus accumbens (NAc). The decreased dopamine responses to
alcohol arose via two mechanisms: an initial activation of stress
hormone receptors in the ventral tegmental area and a subse-
quent increase in alcohol-induced inhibitory neurotransmission.
These results identify the mesolimbic dopamine system as a lo-
cus for multiple neurophysiological interactions between nico-
tine and alcohol.
RESULTS
Nicotine Attenuates Ethanol-Induced DA Release
The initial administration of addictive drugs, such as nicotine and
ethanol, increases basal DA levels in the nucleus accumbens
(NAc) as measured by microdialysis (Di Chiara and Imperato,
1988). We found that simultaneous coadministration of nicotine
and ethanol produces an additive increase in NAc DA release
relative to the response of each drug alone (Figure S1 available
online). To determine whether prior exposure to nicotine influ-
ences ethanol-induced DA release in the NAc, we injected rats
with nicotine or saline 3 hr prior to administering ethanol. Guided
by nicotine’s metabolic half-life in rats of 45 min (Matta et al.,
2007), we chose a 3 hr pretreatment period to decrease any
carryover in the pharmacological effects of nicotine.
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Figure 1. Nicotine Pretreatment Attenuates
Ethanol-Induced DA Release and Increases
Ethanol Self-Administration
(A–C) Rats were injected once with nicotine
(0.4 mg/kg) or saline 3 hr prior to in vivo
ethanol administration (A), 15 hr prior to
in vivo ethanol administration (B), or 40 hr prior to
in vivo ethanol administration (C). Changes in [DA]
were measured in 5 min intervals using micro-
dialysis with HPLC. Ethanol (1.5 g/kg) was infused
i.v. over a 5 min period (shaded vertical bars). *p <
0.05, significantly different from the control by
ANOVA with repeated measures; **p < 0.01; n = 6–
16 rats/group. ‘‘#’’ indicates significant difference
from the control by post hoc ANOVAwith repeated
measures.
(D) Microdialysis probe placements in the NAc for
all rats pretreated with saline (left) or nicotine (right)
(Paxinos and Watson, 2007).
(E) Nicotine increases acquisition of ethanol
self-administration. Rats were pretreated
once with either saline (black bar) or
nicotine (0.4 mg/kg, i.p.; red bar) 3 hr prior to
an initial ethanol exposure. The mean
ethanol intake was then measured over the first four self-administration sessions (45 min/session). **p < 0.01, significantly different from the
control by t test; n = 20, 17. Data are presented as the mean ± SEM. See also Figures S1 and S2.
Neuron
Nicotine Alters Dopamine Responses to AlcoholMicrodialysis samples were collected to follow the change in
extracellular DA levels induced by ethanol administration (Fig-
ure 1). After pretreatment with saline or nicotine, therewas no dif-
ference in the basal DA concentrations prior to ethanol exposure:
1.0 ± 0.2 nM after nicotine pretreatment and 1.0 ± 0.1 nM after
saline pretreatment. To avoid handling-related stress, we admin-
istered ethanol intravenously over a 5min period (Figures 1A–1C,
shaded columns). Ethanol induced a sustained increase in DA
release in the saline control group (Figures 1A–1C, black circles).
Nicotine pretreatment (0.4 mg/kg, intraperitoneally [i.p.], 3 hr
prior) significantly attenuated the ethanol-induced increase in
DA release (Figure 1A, red circles) (group 3 time: F(10,100) =
2.37, p < 0.05). The administered ethanol dose falls within the
typical range tested in rodents (Gonzales et al., 2004) and pro-
duces brain ethanol concentrations in rodents that humans
commonly achieve (Howard et al., 2008). Brain ethanol concen-
trations peaked 10 min after the ethanol infusion and then
decreased to a relatively stable concentration just above
30 mM for more than 30 min (Figure S2). Blood ethanol concen-
trations were 26 ± 4 mM when measured from blood samples
taken 95 min after ethanol administration.
To determine the duration of nicotine’s effect on ethanol-
induced DA release, we increased the interval between the nico-
tine pretreatment and the ethanol exposure to 15 hr and 40 hr,
respectively. Remarkably, the DA release induced by ethanol re-
mained significantly (group 3 time: F(10,250) = 6.16, p < 0.01)
blunted 15 hr after nicotine pretreatment (0.4 mg/kg, i.p.) (Fig-
ure 1B, red circles) compared to the saline control (Figure 1B,
black circles). This effect was less evident 40 hr after nicotine
pretreatment (group 3 time: F(10,150) = 1.31, p > 0.05). How-
ever, a post hoc analysis of the first three postethanol dialysate
samples (plus baseline) revealed a statistical difference between
the nicotine and saline pretreatments (group 3 time: F(5,75) =
2.63, p < 0.05), suggesting at least some influence of nicotine40 hr after administration (Figure 1C). The distribution of the mi-
crodialysis probe placements within the NAc was similar be-
tween the cohort of animals pretreated with nicotine and those
pretreated with saline (Figure 1D), indicating that regional differ-
ences in DA release do not account for these results.
Although the animals were habituated to needle injections, we
further controlled for the stimulus effects of the intraperitoneal in-
jection of nicotine, which could potentially contribute to a stress
response. We pretreated a separate experimental group with
nicotine administered intravenously by cannula 15 hr prior to
ethanol administration. This group displayed the same attenu-
ated DA response to ethanol compared to the group pretreated
with intravenous saline (group3 time: F(10,210) = 5.35, p < 0.01).
Thus, physical handling and the stimulus of the needle injections
during the pretreatment period did not contribute to the inhibitory
effect of nicotine on ethanol-induced DA release.
Nicotine Increases Ethanol Self-Administration
Given that the single nicotine pretreatment decreased ethanol-
induced DA release, we determined whether that same nicotine
pretreatment influenced ethanol self-administration (Smith et al.,
1999). To parallel the 40 hr time course of our microdialysis ex-
periments (see Figure 1), we examined ethanol intake during
the early acquisition of drinking behavior. Early acquisition was
defined as the first four sessions of ethanol self-administration
(one session/day for 45 min/session). Operant responses to
saccharin (0.125%, w/v) were first established, followed by an
introduction of ethanol (2%–4%) into the drinking solutions
over 4 days (Doyon et al., 2005).
We pretreated the rats with either nicotine (0.4 mg/kg, i.p.) or
saline 3 hr prior to an initial ethanol exposure, as in the microdial-
ysis experiments (see Figure 1A). Ethanol intake across the first
four self-administration sessions was significantly higher after
nicotine pretreatment (0.97 g/kg, n = 20) compared to the salineNeuron 79, 530–540, August 7, 2013 ª2013 Elsevier Inc. 531
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Figure 2. Nicotine Initially Activates b2-nAChRs to Alter Ethanol-
Induced DA Release
(A) Pretreatment with DHbE (a b2-nAChR antagonist; 2.5–5.0 mg/kg), at the
same time as nicotine (Nic 15 hr), prevented the attenuation of ethanol-induced
DA release 15 hr later. The control response to ethanol (Sal 15 hr) and the
control response to DHbE pretreatment (no nicotine; n = 4) were combined and
shown for comparison (dashed traces). **p < 0.01, significantly different from
Nic 15 hr by ANOVA with repeated measures.
(B) Pretreatment with MLA (an a7-nAChR antagonist; 5.0 mg/kg), at the
same time as nicotine, was not different from the inhibitory effect of nicotine
alone.
(C) Alterations in [DA] in response to nicotine (0.07 mg/kg, i.v.) were not
different between groups after saline or nicotine pretreatment, suggesting
normal nAChR function after nicotine pretreatment. n = 5–20 rats/group.
(D) Microdialysis probe placements in the NAc for all three data sets shown
above. Data are presented as the mean ± SEM.
Neuron
Nicotine Alters Dopamine Responses to Alcoholpretreatment control (0.75 g/kg, n = 17) (p < 0.01) (Figure 1E).
Rats pretreated with nicotine also initiated significantly more op-
erant responses (44 ± 2) than the saline pretreatment control
(36 ± 2).
To confirm that these effects were specific to ethanol and not
related to the saccharin in the drinking solution, we included a
separate control group that responded for saccharin alone (no
ethanol) (n = 10). This group did not drink significantly more fluid
after nicotine pretreatment (15.6 ± 1.8 ml/session) across four
drinking sessions than the ethanol control rats pretreated with
saline (13.9 ± 0.8 ml/session) (p > 0.05).
Nicotine Attenuates Ethanol-Induced DA Signals via b2*
nAChRs
Neuronal nicotinic acetylcholine receptors (nAChRs) consist of
many subunit combinations, but nicotine exerts its action pri-
marily through two major receptor subtypes containing either
the high-affinity b2 subunit (often with a4 and/or a6 subunits)
or the low-affinity a7 subunit (McGehee and Role, 1995; Nashmi532 Neuron 79, 530–540, August 7, 2013 ª2013 Elsevier Inc.and Lester, 2006; Tapper et al., 2004). To determine which
general nAChR subtype contributed to the nicotine-ethanol
interaction, we selectively blocked b2-containing (b2*) nAChRs
with DHbE or blocked a7* nAChRs with MLA at the time of the
nicotine pretreatment. The attenuation of ethanol-induced DA
release by nicotine pretreatment (15 hr before ethanol) was pre-
vented by DHbE pretreatment in a dose-dependent manner
(group 3 time: F(10,180) = 3.09, p < 0.01) (Figure 2A, traces
with squares), indicating the involvement of b2* nAChRs. By
comparison, blocking a7* nAChRs with MLA did not influence
the interaction between nicotine and ethanol (group 3 time:
F(10,160) = 0.38, p > 0.05) (Figure 2B, trace with squares).
Given that the nicotine-ethanol interaction depended on the
b2* nAChRs, it is possible that this acute nicotine pretreatment
altered the long-term function of the b2* nAChRs. To test this
hypothesis, we examined the effect of nicotine or saline pretreat-
ment (15 hr prior) on nicotine-induced DA release. The nicotine-
induced DA release was not significantly different between those
rats pretreated with nicotine and the control rats pretreated with
saline (group3 time: F(14,112) = 0.79, p > 0.05) (Figure 2C). This
result suggested that acute nicotine pretreatment did not caus-
atively influence the long-term function of the b2* nAChRs within
the DA system. That is, nicotine-induced changes in nAChR
function do not likely explain the results obtained with ethanol.
The distribution of the microdialysis probe placements for these
experiments (Figure 2D) was similar to the placements shown for
the earlier experiments (Figure 1D).
Nicotine Attenuates Ethanol-Induced VTA DA Neuron
Firing
Evidence indicates that ethanol enhances DA release in the NAc
by increasing the firing rate of VTA DA neurons (Foddai et al.,
2004; Gessa et al., 1985). Therefore, we examined whether nico-
tine pretreatment altered the responses of VTA DA neurons to
ethanol. Rats were injected with nicotine or saline 15 hr prior to
the experiment. We then cut midbrain slices and performed
patch-clamp cell-attached recordings to measure the sponta-
neous firing rate of VTA DA neurons before and after applying
ethanol to the bath. DA neurons were recorded from the lateral
VTA and were identified by a combination of factors that were
verified by immunohistochemistry (Figure 3A). We chose DA
neurons based on their location, low pacemaker-like firing rate
(1–5 Hz), long duration action potential, and the presence of a
large hyperpolarization-activated inwardly rectifying cation cur-
rent (Ih) (Chen et al., 2008; Zhang et al., 2010). Thirteen of 14 cells
that displayed these electrophysiological properties were posi-
tive for tyrosine hydroxylase (Figure 3A).
The mean basal firing rate prior to ethanol exposure was
2.4 ± 0.3 Hz after saline pretreatment (n = 11) and 2.7 ± 0.2 Hz
after nicotine pretreatment (n = 11), indicating that the sponta-
neous baseline firing of the DA neurons was unchanged by the
pretreatment. Bath application of ethanol increased the firing
rate of the DA neurons from rats pretreated with saline (Figures
3B and 3C), which is consistent with previous studies (Brodie
et al., 1990; Okamoto et al., 2006). By comparison, ethanol expo-
sure did not significantly alter the firing rate of DA cells from nico-
tine-pretreated rats, and in several cases, there was a reduction
in activity (Figure 3C, red circles). ANOVA confirmed a significant
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Figure 3. Nicotine Pretreatment Attenuates DA Neuron Firing Rates
in VTA Brain Slices
(A) The DA phenotype was confirmed in a separate group of VTA neurons.
Neurobiotin-labeled neurons selected from the lateral VTA possessed low
firing rates (<5 Hz), large Ih currents (>100 pA), and were immunoreactive for
tyrosine hydroxylase (red stain). Scale bar represents 20 mm.
(B) A cell-attached patch electrode recording of a representative DA neuron
before (basal) and after bath ethanol application (50mM). Rats were pretreated
15 hr before with saline (Sal 15 hr) or nicotine (Nic 15 hr).
(C) Percent of basal firing rates in response to ethanol application in the saline
control and the nicotine-pretreated group. n = 11 cells/group. **p < 0.01,
significantly different from the control by ANOVAwith repeatedmeasures; *p <
0.05 by t test. Data are presented as the mean ± SEM.
Neuron
Nicotine Alters Dopamine Responses to Alcoholgroup by time interaction between the saline and nicotine pre-
treatments (F(9,180) = 3.16, p < 0.01).
Nicotine Increases Ethanol-Induced VTA GABA
Transmission
Inhibitory synaptic inputs regulate the spontaneous firing rate of
VTA DA neurons (Grace et al., 2007). In addition to its excitatory
action, ethanol also enhances GABA-mediated inhibitory trans-
mission onto VTA DA neurons (Melis et al., 2002; Theile et al.,
2008). We postulated that the combination of nicotine pretreat-
ment and ethanol exposure shifted the balance between the
inhibitory and excitatory inputs onto DA neurons.
To test this hypothesis, we pretreated rats with saline or nico-
tine 15 hr before performing whole-cell patch-clamp recording
from VTA DA neurons. We measured spontaneous inhibitory
postsynaptic currents (sIPSCs) and separately spontaneous
excitatory postsynaptic currents (sEPSCs, described below).
To examine GABAergic activity, we blocked glutamate receptors
with DNQX (20 mM) and AP5 (50 mM). Nicotine pretreatment did
not significantly alter the mean basal sIPSC frequency between
the groups (saline pretreatment control, 2.7 ± 0.3 Hz; nicotine
pretreatment, 3.4 ± 0.6 Hz; n = 7, 8; p > 0.05) or the mean basal
sIPSC amplitudes (saline pretreatment control, 27.9 ± 4.2 pA;
nicotine pretreatment, 27.9 ± 2.8 pA; n = 7, 8; p > 0.05). In controlDA neurons from saline-pretreated rats, bath-applied ethanol
(50 mM) induced a marginal increase in the sIPSC frequency
(black data, Figures 4A and 4C; n = 7) (Theile et al., 2008). By
contrast, in DA neurons from nicotine-pretreated rats, ethanol
caused a much greater potentiation of the sIPSC frequency
above the control response (red data, Figures 4B and 4C; n =
8; p < 0.01) with no change in sIPSC amplitude. We repeated
this experiment using a lower bath ethanol concentration
(25 mM) and determined that the effect of nicotine and ethanol
on sIPSC frequency was still present. Nicotine pretreatment
increased the sIPSC frequency induced by 25 mM ethanol by
approximately 24% (n = 6/group, p < 0.05) compared to the sa-
line pretreatment response, whereas in 50 mM ethanol the
percent increase between the nicotine and saline pretreatment
was approximately 56% (Figure 4C; n = 7, 8; p < 0.01).
An increase in the frequency, but not the amplitude, of the
sIPSCs after nicotine pretreatment suggested a presynaptic
change in GABA transmission. To investigate whether a presyn-
aptic mechanism rather than a postsynaptic mechanism was at
work, we measured the paired-pulse ratio of evoked IPSCs un-
der different pretreatment conditions after ethanol application.
Differences in the amplitudes between two consecutively
evoked IPSCs (i.e., the paired-pulse ratio) suggest a transient
change in the probability of GABA release. Baseline paired-pulse
ratios were not different between the saline pretreatment and
nicotine pretreatment groups (p > 0.05). Application of ethanol
decreased the paired-pulse ratio in both the saline pretreatment
control (n = 14) and the nicotine pretreatment group (n = 21). The
magnitude of this paired-pulse depression, however, was signif-
icantly greater (p < 0.05) after the nicotine pretreatment (78.6%±
3.4%) compared to the saline pretreatment (90.0% ± 3.8%) (Fig-
ure 4D), which is consistent with a presynaptic change in GABA
transmission.
To confirm that changes in ethanol-induced GABA transmis-
sion contribute to changes in DA neuron responses, we blocked
GABAA receptors prior to the bath application of ethanol. We
applied picrotoxin, a noncompetitive GABAA receptor antago-
nist, to slices containing the VTA and then measured the sponta-
neous firing rate of DA neurons in response to bath-applied
ethanol. Picrotoxin (50 mM) did not significantly alter the baseline
firing rate of DA neurons between the nicotine and saline pre-
treatments. However, in the presence of picrotoxin (50 mM),
ethanol no longer inhibited DA neuron firing after nicotine pre-
treatment (red circles compared to dotted line, Figure 4E). In
the presence of picrotoxin, nicotine and saline pretreatment
groups showed a similar increase in firing rate in response to
ethanol (group 3 time: F(9,144) = 0.30, p > 0.05). These results,
combined with the increase in spontaneous and evoked GABA
IPSCs, indicate that nicotine pretreatment increased ethanol-
induced GABA transmission onto DA neurons, thereby reducing
DA neuron excitability.
To examine whether the effect of nicotine was selective to
the actions of ethanol, we recorded from DA neurons and
measured sIPSCs induced by other drugs of abuse after nicotine
or saline pretreatment. Bath-applied nicotine (1 mM) increased
the sIPSC frequency similarly in both treatment groups (saline
pretreatment, 156% ± 24% of basal; nicotine pretreatment,
155% ± 25% of basal; n = 5–6, p > 0.05), indicating no causativeNeuron 79, 530–540, August 7, 2013 ª2013 Elsevier Inc. 533
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Figure 4. Nicotine Increases Ethanol-
Induced GABAergic Transmission onto VTA
DA Neurons
(A) Cells from rats pretreated with saline (15 hr
before ethanol) showed a small increase in the
sIPSC frequency after bath ethanol application.
(B) Nicotine pretreatment increased the sIPSC
frequency induced by ethanol.
(C) Mean changes in the sIPSC frequency after
ethanol application after pretreatment with saline or
nicotine. n = 7, 8 cells/group. **p < 0.01, signifi-
cantly different by t test.
(D) Nicotine pretreatment decreased the paired-
pulse ratio induced by ethanol. Interstimulus inter-
val = 70 ms. n = 14, 21 cells/group. *p < 0.05.
(E) In the presence of the GABAA receptor antag-
onist picrotoxin (50 mM), ethanol-induced DA
neuron firing was not inhibited by nicotine pre-
treatment and was similar to the response of the
saline control. The effect of nicotine pretreatment
and ethanol application in the absence of picro-
toxin from Figure 3C is shown for comparison
(dotted line). Recordings were in a cell-attached
configuration. n = 7, 11 cells/group. Data are pre-
sented as the mean ± SEM.
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Nicotine Alters Dopamine Responses to Alcoholeffect of the nicotine pretreatment. Because our data suggest
adaptations in GABA transmission, we also tested diazepam, a
benzodiazepine that positively modulates GABAA receptors
(Tan et al., 2010). Nicotine pretreatment increased the sIPSC fre-
quency induced by diazepam by approximately 63% compared
to the saline pretreatment response (n = 6, 7/group, p < 0.01),
indicating that nicotine pretreatment specifically altered the
GABAergic responses to drugs such as ethanol and diazepam.
The interaction between nicotine and ethanol could potentially
alter the excitatory glutamatergic signals that regulate VTA DA
neurons (Xiao et al., 2009). We tested this possibility by perform-
ing whole-cell patch-clamp recordings of sEPSCs before and af-
ter ethanol application to the bath. The basal sEPSC frequency
was not different between the saline pretreatment control cells
(1.8 ± 0.3 Hz) and the nicotine pretreatment cells (1.2 ± 0.2 Hz;
n = 7, p > 0.05). Subsequent application of ethanol increased
the sEPSC frequency to a similar degree in both groups (saline
pretreatment control, 165% ± 7%; nicotine pretreatment,
169% ± 8%; n = 7, p > 0.05).
Interactions between Nicotine and Ethanol Require
Stress Hormones
To understand how nicotine and ethanol interact and impinge on
the DA and GABA systems, we considered several possible
mechanisms. A functional alteration in nAChRs by nicotine is
not likely to contribute to thenicotine-ethanol interactionbecause
the DA release (see Figure 2C) and the sIPSCs induced by nico-
tine were unaffected by nicotine pretreatment. Moreover, the re-
covery from desensitization is more rapid than 15 to 40 hr (Lester
and Dani, 1995; Wooltorton et al., 2003). Nicotine can enhance
glutamatergic synaptic plasticity onto DA neurons (Gao et al.,
2010; Mansvelder et al., 2002; Saal et al., 2003), but the fact534 Neuron 79, 530–540, August 7, 2013 ª2013 Elsevier Inc.that nicotine pretreatment did not alter the baseline DA firing
rates and did not alter sEPSCs makes this explanation unlikely.
As an alternative, we hypothesized that nicotine administration
altered the DA and GABA responses to alcohol through a neuro-
endocrine signal (Armario, 2010). Stress-related hormones, such
as glucocorticoids, cause long-term homeostatic changes in
neural function and influence DA and GABA transmission (Barrot
et al., 2000; Butts et al., 2011; Joe¨ls and Baram, 2009).
Nicotine activates the HPA axis to increase plasma levels of
corticosterone (Lutfy et al., 2012), the principle glucocorticoid
in rodents, which we confirmed (Figure S3). To determine
whether glucocorticoid receptor activation during nicotine
pretreatment contributes to subsequent alterations in ethanol-
induced DA release, we systemically blocked glucocorticoid re-
ceptors with RU486 (Cadepond et al., 1997) prior to nicotine
pretreatment. Pretreatment with RU486 (Figure 5A, blue circles)
prevented the inhibitory effect of nicotine on ethanol-induced DA
release (group3 time: F(10,240) = 4.75, p < 0.01). This increased
DA response to ethanol after RU486 and nicotine pretreatment
was not distinguishable from the control rats pretreated with sa-
line alone or RU486 alone (Figure 5A, dashed trace).
These results suggested that stress hormone receptor activa-
tion within the VTA, after nicotine pretreatment, attenuated the
subsequent DA response to ethanol. To test this hypothesis,
we blocked glucocorticoid receptors locally in the VTA with
RU486 prior to nicotine pretreatment. The control group that
received a local intra-VTA microinfusion of vehicle followed by
nicotine pretreatment showed a decreased DA response to
ethanol 15 hr later (Figure 5B, red circles), consistent with our
previous data (see Figure 1). This inhibitory effect of nicotine
pretreatment was prevented by intra-VTA microinfusion of
RU486 prior to nicotine pretreatment (Figure 5B, blue circles)
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Figure 5. Nicotine Requires Stress Hormone Signaling to Alter
Ethanol-Induced DA Release and Ethanol Self-Administration
(A) Rats were injected with RU486 (40 mg/kg) 15 min prior to nicotine
(0.4 mg/kg) or saline pretreatment. Fifteen hours later, changes in extracellular
[DA] in response to ethanol (shaded vertical bar) were measured. Control
subjects that received RU486 alone were combined with the saline controls
from Figure 1B as these groups were not statistically different. n = 9–16 rats/
group. **p < 0.01, significantly different from the nicotine pretreatment by
ANOVA with repeated measures.
(B) The effect of microinfusion of RU486 or vehicle into the VTA prior to
nicotine pretreatment on the DA response to ethanol 15 hr later. *p < 0.05,
n = 8/group.
(C) VTA microinfusion sites for all rats pretreated with RU486 (blue circles) or
vehicle (red circles). PIF, parainterfascicular nucleus; PBP, parabrachial pig-
mented nucleus.
(D) Systemic RU486 blocked the increase in ethanol self-administration
induced by nicotine pretreatment, as shown in Figure 1E. Ethanol intake in the
saline pretreatment control is indicated by the dashed line. **p < 0.01, signif-
icantly different from the nicotine pretreatment by t test, n = 20, 12. Data are
presented as the mean ± SEM. See also Figure S3.
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Nicotine Alters Dopamine Responses to Alcohol(group 3 time: F(10,140) = 2.43, p < 0.05). We should note that
the intra-VTA RU486 did not completely reverse the effect of
nicotine pretreatment. A post hoc comparison indicated a
significant difference between the saline control (Figure 5B,
dashed line) and the group pretreated with intra-VTA RU486 +
Nic (F(10,220) = 2.01, p < 0.05). The microinfusion sites were
dispersed mainly in the more ventral VTA, including the
anterior and posterior regions (Figure 5C). There was no con-
sistent relationship between the microinfusion site and the
individual DA responses to ethanol in either group. As a nega-
tive control, microinfusion of RU486 outside and adjacent to
the VTA did not reverse the inhibitory effect of nicotine pretreat-
ment (n = 3).
To determine whether stress-related signals also contributed
to increased ethanol consumption after nicotine pretreatment(as in Figure 1E), we pretreated rats with RU486 prior to nicotine
administration and then monitored early acquisition of ethanol
self-administration over the first four sessions. RU486 pretreat-
ment prevented the increased ethanol self-administration
induced by nicotine pretreatment (Figure 5D). The mean ethanol
intake for the group pretreated with RU486 and nicotine (0.74 ±
0.06 g/kg/session, n = 12) was significantly lower than the nico-
tine pretreatment alone (0.97 g/kg; n = 17) (p < 0.01) and nearly
identical to the saline pretreatment control (Figure 5D, dashed
line). Thus, nicotine required the activation of stress hormone re-
ceptors to enhance subsequent ethanol self-administration.
Because local infusions of RU486 into the VTA prevented the
inhibition of ethanol-induced DA release, we hypothesized that
stress hormone action altered ethanol-induced GABA transmis-
sion onto DA neurons. Therefore, we pretreated rats with RU486
prior to nicotine pretreatment and measured ethanol-induced
sIPSCs 15 hr later. The nicotine-pretreatment potentiation of
the sIPSC frequency by ethanol was prevented by RU486 pre-
treatment (Figures 6A and 6B) (p < 0.05). The average sIPSC fre-
quency induced by ethanol (relative to basal) was 187% ± 12%
after nicotine pretreatment (Figure 6B, red bar) and 118% ± 8%
after RU486 and nicotine pretreatment (Figure 6B, blue bar). In
addition, the enhanced paired-pulse depression after the nico-
tine pretreatment (78.6% ± 3.4%; see Figure 4D) was also pre-
vented by RU486 (92.1% ± 3.0%; n = 15; data not shown) (p <
0.05). These results and others indicate that stress hormone re-
ceptor activation in response to nicotine pretreatment altered
ethanol-induced GABA network activity in the VTA.
DISCUSSION
Acute pretreatment with nicotine induced a long-lasting attenu-
ation of ethanol-induced DA signals within the mesoaccumbens
pathway. The decreased ethanol-induced DA signals were due
to an increase in GABAergic inhibition of DA neurons and a
consequent decrease in VTA DA neuron firing. These nicotine-
induced neuroadaptations required a stress hormone signal
that acted significantly within the VTA. Concomitant with these
physiological changes, we also show that increases in ethanol
self-administration induced by nicotine were prevented by
RU486, a glucocorticoid/progesterone receptor antagonist (Ca-
depond et al., 1997).
In addition to other interactions with ethanol (Al-Rejaie and
Dar, 2006; Collins et al., 1996; Gulick and Gould, 2008; Lo´pez-
Moreno et al., 2008), nicotine exposure influences subsequent
ethanol consumption and abuse (Barrett et al., 2006; Grant,
1998; Leˆ et al., 2003; Morgen et al., 2008; Smith et al., 1999).
Although the development of drug abuse involves the mesolim-
bic DA system, there are little mechanistic data indicating how
nicotine influences DA responses to ethanol. Our results suggest
that nicotine acts through stress hormone signaling pathways in
the VTA to enhance subsequent ethanol-induced GABAergic
drive onto DA neurons, thereby decreasing ethanol-induced
DA signals. The inhibitory effect on DA signals was fully ex-
pressed for at least 15 hr and waned after 40 hr, which paralleled
the time course of changes in ethanol self-administration
induced by nicotine. A blunted DA system has been associated
with increased impulsivity (Reuter et al., 2005) and increasedNeuron 79, 530–540, August 7, 2013 ª2013 Elsevier Inc. 535
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Figure 6. Nicotine Requires Stress Hor-
mone Signaling to Increase Ethanol-
Induced GABA Transmission onto VTA DA
Neurons
(A) Compared to cells from rats pretreated with
nicotine alone (15 hr before ethanol), those pre-
treated with the glucocorticoid antagonist RU486
prior to nicotine did not show a potentiation of the
sIPSC frequency after bath ethanol application.
(B) Mean changes in the sIPSC frequency after
ethanol application after pretreatmentwith nicotine
or RU486 plus nicotine. The dashed line indicates
the saline control response from Figure 4C. n = 7, 8
cells/group. **p < 0.01, significantly different by
t test. Data are presented as the mean ± SEM.
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Nicotine Alters Dopamine Responses to Alcoholsusceptibility to drug and alcohol abuse (Martinez et al., 2005;
Volkow et al., 1996; Zhang et al., 2012). Previous studies have
shown that higher ethanol preference in mice corresponds to
lower DA neuron responses to ethanol (Brodie and Appel,
2000). Thus, increased ethanol self-administration in response
to nicotine may arise from increased GABAergic inhibition of
DA neurons. This hypothesis is consistent with evidence that
disruption of GABAergic transmission modulates ethanol con-
sumption (Chester and Cunningham, 2002; Nie et al., 2011;
Nowak et al., 1998).
Nicotine pretreatment (15 hr prior) did not alter the baseline
parameters we examined, including basal DA concentration,
basal DA neuron firing rate, basal sEPSC frequency, and basal
sIPSC frequency, nor did nicotine pretreatment alter nicotine-
induced DA release (Figure 2C) or nicotine-induced sIPSCs.
The effects of nicotine pretreatment, however, were revealed in
the presence of ethanol (and diazepam), drugs that strongly
modulate GABA transmission. Ethanol increases GABA release
onto DA neurons (Melis et al., 2002; Theile et al., 2008; Wanat
et al., 2009), while also enhancing GABAA-receptor function in
many systems (Glykys et al., 2007; Harris, 1999; Kumar et al.,
2009). Because glutamatergic transmission was not altered
significantly, the present results suggest that the combination
of nicotine pretreatment and ethanol exposure shifted the bal-
ance between the inhibitory and excitatory input onto DA neu-
rons in favor of inhibition. This effect probably contributed to
the blunted DA response to ethanol, which we directly tested
by blocking GABAA-mediated inhibition with picrotoxin (Fig-
ure 4E). Nicotine also increased the inhibitory responses to diaz-
epam, suggesting that nicotine alteredGABAA receptor signaling
pathways. Adaptations in the inhibitory input onto VTA DA neu-
rons could arise from local GABA neurons and various afferent
projections, including prominent GABAergic pathways from the
rostromedial tegmental nucleus (Hong et al., 2011), the ventral
pallidum (Grace et al., 2007), and the nucleus accumbens (Xia
et al., 2011).
We hypothesize that adaptations arising from the stress hor-
mone response to nicotine were revealed by ethanol’s potent
action on GABAergic transmission. Most drugs of abuse acti-
vate the HPA axis, but previous studies have not explicitly
linked stress hormone activity to a specific drug interaction.
Nicotine induces the release of glucocorticoids and other
stress-related hormones that mediate various long-term ho-536 Neuron 79, 530–540, August 7, 2013 ª2013 Elsevier Inc.meostatic processes (Armario, 2010; Joe¨ls and Baram, 2009),
including regulation of GABAergic activity (Di et al., 2009;
Gunn et al., 2011; Wirth, 2011). We should note that RU486 is
an antagonist for both the glucocorticoid and the progesterone
receptor (Cadepond et al., 1997). Progesterone and its metab-
olites are produced in the brain and participate in stress re-
sponses (Wirth, 2011), and thus progesterone and glucocorti-
coid receptors could contribute to interactions between
nicotine and ethanol. Our demonstration that nicotine enhances
ethanol-induced VTA GABA transmission through a stress hor-
mone signal is consistent with evidence that GABAergic neuro-
active hormones contribute to ethanol self-administration (Big-
gio et al., 2007; Helms et al., 2012; Morrow et al., 2009).
These results complement previous studies showing a critical
role for glucocorticoids in alcohol reward and in the transition
to compulsive alcohol drinking (Rotter et al., 2012; Vendruscolo
et al., 2012).
We found no evidence of long-term changes in nAChR func-
tion after one nicotine exposure. However, activation of
nAChRs in the brain stem may contribute to the initial response
of the HPA axis to nicotine (Armario, 2010), which our results
suggest involves high-affinity b2* nAChRs (Figure 2A). Blocking
the initial stress hormone response locally in the VTA prevented
the long-term alterations in ethanol-induced DA release (Fig-
ure 5B) and thus identified the VTA as a locus for mechanistic
interactions between nicotine and ethanol. Interestingly, local
VTA infusion of RU486 to antagonize stress receptors did not
completely reverse the effects of nicotine pretreatment on
ethanol-induced DA release compared to the saline control.
This incomplete effect could arise from a partial diffusion of
RU486 in the VTA, but it is also feasible that nicotine pretreat-
ment acted outside of the VTA to induce neuroadaptations
that regulate DA signals.
In summary, we provide evidence that nicotine pretreatment
decreases ethanol-induced DA transmission owing to increased
GABAergic inhibition onto DA neurons. These responses to nico-
tine pretreatment, including increased ethanol intake, required
an initial stress hormone signal. These results support the hy-
pothesis that the actions of drugs of abuse recruit neuroendo-
crine pathways (Kenna et al., 2012; Koob, 2008; Richards
et al., 2011). Our data suggest a neurophysiological basis for
the observation that nicotine use can increase the reinforcing
properties of alcohol.
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Nicotine Alters Dopamine Responses to AlcoholEXPERIMENTAL PROCEDURES
Subjects
Long-Evans rats (Harlan Sprague) weighing between 300–500 g were used.
The rats were handled and weighed for at least 3 days and commonly more
than a week prior to surgery and testing, and the rats were housed in a humid-
ity-and temperature-controlled (22C) environment under a 12 hr light/dark
cycle. The rats had food and water available ad libitum in the home cage. All
procedures complied with guidelines specified by the Institutional Animal
Care and Use Committee at Baylor College of Medicine.
Surgical Procedures
For the microdialysis experiments, each animal was implanted with an intrave-
nous catheter through the jugular vein and a stainless steel guide cannula
(21G) (Plastics One). The surgery occurred under isoflurane anesthesia
(1.5%–2.5% in 100%O2, 1 l/min). The catheters were constructed with Silastic
tubing (0.30 mm ID, 0.64 mm OD; Dow Corning) with one end modified with a
22G cannula (Plastics One). The microdialysis guide cannulae were positioned
as follows (relative to bregma): +2.1 mm anterior-posterior, +1.1 mm medial-
lateral, 4.0 mm ventral to the skull surface (Paxinos and Watson, 2007).
The experiments were conducted after a minimum recovery period of 3 days.
Drugs and Experimental Design
All drugs (Sigma-Aldrich) were dissolved in sterile saline, except Mifepristone
(RU486), which was dissolved in DMSO. Pretreatment with nicotine tartrate
(0.4 mg/kg, freebase, i.p.), or an equivalent volume of saline, occurred 3–
40 hr prior to the experiments. Dihydro-b-erythroidine (DHbE, 2.5 or
5.0 mg/kg) or methyllycaconitine (MLA, 5.0 mg/kg) was administered (i.p.)
simultaneously with nicotine. RU486 was administered 15 min prior to nicotine
pretreatment at a dose of 40 mg/kg (Saal et al., 2003). We opted for this dose
because of the limited capacity of RU486 to cross the blood-brain barrier (Hei-
kinheimo and Kekkonen, 1993). The intra-VTA concentration of RU486 was
(10 ng/0.5 ml) and 0.5 ml of the solution was delivered by pump over 1 min (Se-
gev et al., 2012). Themicroinfusion injector was left in place for 2 additional min
and then removed. The infusion cannula was aimed at the following VTA coor-
dinates (relative to bregma): +5.7 mm anterior-posterior, +1.0 mm medial-
lateral, 7.1 mm ventral to the skull surface (Paxinos and Watson, 2007). After
the experiments, Chicago Sky blue was injected into the VTA to determine the
location of the microinfusion.
Baseline samples were collected (15–30 min), followed by a timed intrave-
nous (i.v.) drug infusion (i.e., ethanol or nicotine). The i.v. administration route
circumvents handling-related stress associated with a needle injection (Dong
et al., 2010). For the i.v. ethanol experiments, the rats received 1.5 g/kg ethanol
(20% in sterile saline, v/v, i.v.) over 5 min. Two hours prior to the experiment,
rats were administered a similar volume of vehicle (sterile saline) to habituate
them to the stimulus effects of the infusion. For the i.v. nicotine experiments
(Figure 2C), the rats were infused with saline or nicotine (0.07 mg/kg) over
5 min (Palmatier et al., 2008).
In Vivo Microdialysis
The active dialysis membrane (2.0 mm) was made of hollow cellulose fiber (in-
ner diameter = 200 mm; molecular weight cutoff = 18,000; Spectrum Labora-
tories). The inlet and outlet to the membrane was composed of fused-silica
tubing (inner diameter = 40 mm; Polymicro Technologies). The microdialysis
probes were perfused with artificial cerebral spinal fluid (ACSF): 149 mM
NaCl, 2.8 mM KCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 0.25 mM ascorbic acid,
and 5.4 mM D-glucose. At least 14 hr before the experiment, we lowered the
probes into the brain through the guide cannula. The perfusion flow rate was
set to 2.0 ml/min. Each sample vial was manually changed and immediately
stored at 80C until analyzed.
Dopamine Analysis
The HPLC system included a pump (Model 582; Thermo Scientific), an auto-
sampler (Model 542; Thermo Scientific), and an HR-3.2 3 80 mm column
(3 mm particle size; Thermo Scientific). A coulometric cell (5014B; Thermo Sci-
entific) was connected to a Coulochem II detector. The mobile phase
comprised of citric acid (4.0 mM), sodium dodecyl sulfate (3.3 mM), sodium di-hydrogen phosphate dehydrate (100.0 mM), and ethylenediaminetetraacetic
acid (0.3 mM), acetonitrile (15%), and methanol (5%). The autosampler mixed
9.5 ml of the dialysate with ascorbate oxidase (EC 1.10.3.3; 162 units/mg;
Sigma-Aldrich) prior to injection. DA signals were acquired with 501 chroma-
tography software and Chromeleon Software (Thermo Scientific). Quantifica-
tion of dialysate DA concentration was carried out by comparing the peak
area to external standards (0–2.5 nM).
Histology
The rats were overdosed with pentobarbital (120 mg/kg, i.v.). Saline was
perfused through the heart, followed by 10% formalin (v/v). The brains were
removed and immersed in 10% formalin for at least 2 days. The brains were
cut into 75 mm coronal sections (Leica Microsystems) and stained with cresyl
violet as indicated by the figures defining anatomical placements.
Midbrain Slices and Electrophysiology
Horizontal slices (220 mm) containing the VTA were cut from Long-Evans rats
(21–30 days old) and placed in ice-cold, oxygenated ACSF: 205 mM sucrose,
2.5 mM KCl, 21.4 mM NaHCO3, 1.2 mM NaH2PO4, 0.5 mM CaCl2, 7.5 mM
MgSO4, 11.1 mM dextrose, and 95% O2/5% CO2. The slices were maintained
at 32C in ACSF buffer for 20–40 min, then at room temperature for 40–60 min,
and transferred to a holding chamber and perfused (2 ml/min at 32C) with
the following: 120.0 mM NaCl, 3.3 mM KCl, 25.0 mM NaHCO3, 1.2 mM
NaH2PO4, 2.0 mMCaCl2, 1.0 mMMgCl2, 10.0 mM dextrose, and 20.0 mM su-
crose. Patch electrodes made of thin-walled borosilicate glass had resis-
tances of 1.5–2.5 MU when filled with the internal solution 135.0 mM KCl,
12.0 mM NaCl, 2.0 mM Mg-ATP, 0.5 mM EGTA, 10.0 mM HEPES, and
0.3 mM Tris-GTP (pH 7.2–7.3). The firing rates of VTA DA neurons were re-
corded in a cell-attached configuration in passive voltage-follower mode.
For the whole-cell recordings, the cutting and recording solutions were
similar to those used for the cell-attached recordings, with the exception of
20.0 mM sucrose and the addition of 120.0 mM NaCl in the ACSF. IPSCs
and EPSCs were recorded in voltage-clamp mode while holding the cells at
60 mV. While recording IPSCs, glutamatergic synaptic transmission was in-
hibited by 6,7-dinitroquinoxaline-2,3-dione (DNQX, 20 mM) and DL-2-amino-5-
phosphonopentanoic acid (AP5, 50 mM) (Tocris Bioscience). Ethanol-induced
sIPSCs were blocked by the GABAA-receptor antagonist picrotoxin (50 mM;
Sigma-Aldrich). For the paired-pulse evoked IPSC recordings, a bipolar tung-
sten stimulating electrode was placed 50–100 mm rostral to the recording elec-
trode. Pairs of constant-current pulses (100 ms duration, 20–200 mA amplitude)
were applied every 10 s at an interstimulus interval of 70 ms. To better isolate
sEPSCs, we adjusted the composition of the internal solution as follows:
136.0 mM K-gluconate, 1.0 mM NaCl, 10.0 mM HEPES, 0.5 mM EGTA,
2.0 mM Mg-ATP, and 0.3 mM Tris-GTP (pH 7.2–7.3).
DA neurons were identified in the lateral VTA by their morphology, low firing
frequency (1–5 Hz), and the presence of a large Ih current, which together
correlate (>95%) with tyrosine hydroxylase (TH)-positive cells (Chen et al.,
2008; Zhang et al., 2010). Recordings were made using an Axopatch 200B
amplifier (Molecular Devices), filtered at 10 kHz, digitized at 20 kHz using
pClamp 9.2 (Digidata Interface, Molecular Devices), and analyzed offline using
Clampfit 9.2.
Immunohistochemistry
To validate the identification of DA neurons, we used neurobiotin backfills and
TH double labeling. The recording pipette contained 0.3% neurobiotin (Vector
Laboratories). Slices were fixed with 10%neutral formalin phosphate buffer for
12–24 hr, incubated in a blocking solution containing 3% normal goat serum
solution and 0.3% Triton X-100 for 2 hr, and then incubated overnight with pri-
mary anti-TH (1:100; Chemicon) at 4C. The slices were then rinsed with PBS
and treated with the secondary antibody Cy3-conjugated donkey anti-rabbit
IgG (1:200) and AMCA-conjugated streptavidin (1:1,000; Jackson
ImmunoResearch).
Operant Ethanol Self-Administration
Standard operant chambers (Med Associates) were used for the self-adminis-
tration experiments. Activation of an interior chamber light and presentation of
a retractable lever accompanied the start of each session. Depression of theNeuron 79, 530–540, August 7, 2013 ª2013 Elsevier Inc. 537
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Nicotine Alters Dopamine Responses to Alcohollever triggered the entry of a retractable drinking spout on the opposite side of
the wall. Each lever press resulted in 15 s of access to the drinking spout (a
fixed ratio-1 reinforcement schedule). Each session lasted 45 min. The rats
lived in the same quiet room in which daily training sessions occurred, and
the rats were typically trained one at a time to avoid any auditory distractions
from activity in neighboring chambers.
The rats were trained to lever press for saccharin reinforcement (0.125%,
w/v). Consistent responses for saccharin occurred in 4–8 days. Three hours
prior to their first ethanol exposure, the animals were injected with nicotine
(0.4 mg/kg) or saline. The rats were exposed to ethanol by gradually adding
ethanol (2%–4%, v/v) into their saccharin solution over a 4-day period (Doyon
et al., 2005; Roberts et al., 1999). Consumption was monitored by measuring
the volume of liquid in the drinking bottle before and after the session. Body
weights were measured each day.Statistical Analysis
ANOVA with repeated measures (in SPSS for Windows) was used to analyze
the dialysate DA concentrations, the DA neuron firing rates, and the daily
ethanol intake. For analysis of action potential firing, the raw data (in Hz)
were converted into a percentage of basal, and the last three bins (2 min
each) were used as the baseline. A two-tail t test assuming equal variance
was used to assess differences between mean sIPSC and sEPSC frequency,
as well as mean behavioral responses. Significance for all analyses was deter-
mined by p < 0.05.SUPPLEMENTAL INFORMATION
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